Mathew W. Moore, PhD
Principal and Co-Founder of ResearchDx, Dr. Mathew W. Moore is a distinguished worldwide leader in the field of molecular diagnostic development. He can be frequently seen behind the podium at international conferences speaking on Companion Diagnostics and Next-Gen Sequencing, among other topics. Dr. Moore, an Australian expatriate, is a seasoned industry expert, technology advocate, and regulatory specialist. Previously Vice President of Research and Development of Neogenomics, Inc., Dr. Moore brings his dedication to strong customer service and a collaborative client focus to ResearchDx.
As Vice President of Research and Development for CombiMatrix Molecular Diagnostics, Inc., Dr. Moore was responsible for the oncology, and developmental disorders programs. Previously he served as Senior Scientist with US Labs, a division of Laboratory Corporation of America (LabCorp), and as Director of product development at Response Genetics. These past responsibilities provide ResearchDx with a highly respected reputation in the industry as well as a collaborative focus on client goals.
Dr. Moore received his Bachelor of Science degree in Biotechnology, graduating with honors. He received his PhD in Biotechnology from the University of New South Wales in Sydney, Australia.